Namwiwat Medical (Thailand) Market Value
| NAM Stock | 4.72 0.18 3.96% |
| Symbol | Namwiwat |
Namwiwat Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Namwiwat Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Namwiwat Medical.
| 11/12/2024 |
| 12/12/2024 |
If you would invest 0.00 in Namwiwat Medical on November 12, 2024 and sell it all today you would earn a total of 0.00 from holding Namwiwat Medical or generate 0.0% return on investment in Namwiwat Medical over 30 days.
Namwiwat Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Namwiwat Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Namwiwat Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.5 | |||
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 6.45 | |||
| Value At Risk | (2.02) | |||
| Potential Upside | 2.46 |
Namwiwat Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Namwiwat Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Namwiwat Medical's standard deviation. In reality, there are many statistical measures that can use Namwiwat Medical historical prices to predict the future Namwiwat Medical's volatility.| Risk Adjusted Performance | 0.013 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | (0.07) | |||
| Treynor Ratio | 0.0286 |
Namwiwat Medical Backtested Returns
Namwiwat Medical has Sharpe Ratio of -0.0425, which conveys that the firm had a -0.0425% return per unit of risk over the last 3 months. Namwiwat Medical exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Namwiwat Medical's Mean Deviation of 1.05, downside deviation of 1.5, and Risk Adjusted Performance of 0.013 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.2, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Namwiwat Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Namwiwat Medical is expected to be smaller as well. At this point, Namwiwat Medical has a negative expected return of -0.0544%. Please make sure to verify Namwiwat Medical's sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to decide if Namwiwat Medical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.55 |
Modest predictability
Namwiwat Medical has modest predictability. Overlapping area represents the amount of predictability between Namwiwat Medical time series from 12th of November 2024 to 27th of November 2024 and 27th of November 2024 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Namwiwat Medical price movement. The serial correlation of 0.55 indicates that about 55.0% of current Namwiwat Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Namwiwat Medical lagged returns against current returns
Autocorrelation, which is Namwiwat Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Namwiwat Medical's stock expected returns. We can calculate the autocorrelation of Namwiwat Medical returns to help us make a trade decision. For example, suppose you find that Namwiwat Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Namwiwat Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Namwiwat Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Namwiwat Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Namwiwat Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Namwiwat Medical Lagged Returns
When evaluating Namwiwat Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Namwiwat Medical stock have on its future price. Namwiwat Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Namwiwat Medical autocorrelation shows the relationship between Namwiwat Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Namwiwat Medical.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio Architect